To transform the lives of cancer patients by unleashing the power of highly potent tumor-selective immuno-oncology therapies
What tumor-selective immunotherapy could mean for cancer patients
Chrissy, a chef and mother of 2, was diagnosed with lung cancer. She has been committed to treating the disease aggressively, but her therapies have caused severe side effects, including severe dehydration, swelling, vascular leak syndrome, fatigue, dizziness, mouth sores, back pain, and heartburn. Minimizing toxicity with a tumor-selective approach could allow for more effective anti-tumor treatment without debilitating adverse events for patients like Chrissy in the future.